1Ribacoba Montero R, Martinez-Faedo C, Salas-Puig J. Polycystic ovary syndrome and valproic acid. Rev Neurol, 2003, 37(10): 975-982 被引量：1
2Bilo L, Meo R, Valentino R, et al. Characterization of reproductive endocrine disorders in women with epilepsy. J Clin Endocrinol Metab, 2001, 86(7): 2950-2956 被引量：1
3Joffe H, Hall JE, Cohen LS, et al. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders. Harv Rev Psychiatry, 2003, 11(2): 99-108 被引量：1
4Verrotti A, Greco R, Latini G, et al. Endocrine and metabolic changes in epileptic patients receiving valproic acid. J Pediatr Endocrinol Metab, 2005, 18(5): 423-430 被引量：1
5Meo R, Bilo L. Polycystic ovary syndrome and epilepsy: a review of the evidence. Drugs, 2003, 63(12): 1185-1227 被引量：1
6Betts T, Yarrow H, Dutton N. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. Seizure, 2003, 12(6): 323-329 被引量：1
7O'Donovan C, Kusumakar V, Graves GR. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psychiatry, 2002, 63(4): 322-330 被引量：1
8Wood JR, Nelson-Degrave VL, Jansen E, et al. Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiol Genomics, 2005, 20(3): 233-243 被引量：1
9Ribacoba-Montero R, Martinez-Faedo C, Diaz-Diaz C, et al. Remission of polycystic ovary syndrome associated with valproic acid in an epileptic female.Rev Neurol, 2003, 36(7): 639-642 被引量：1
10Kaplan PW. Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology, 2004, 63(10), 13-23 被引量：1
